BCI
CVS icon

Brinker Capital Investments’s CVS Health CVS Stock Holding History

Brinker Capital Investments’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.71M Buy
45,562
+374
+0.8% +$33.4K 0.04% 401
2026
Q1 		$3.25M Sell
45,188
-11,514
-20% -$887K 0.03% 529
2025
Q4 		$4.5M Buy
56,702
+12,764
+29% +$1.01M 0.03% 477
2025
Q3 		$3.31M Sell
43,938
-8,091
-16% -$555K 0.03% 579
2025
Q2 		$3.59M Buy
52,029
+1,858
+4% +$122K 0.03% 516
2025
Q1 		$3.4M Sell
50,171
-3,782
-7% -$226K 0.03% 479
2024
Q4 		$2.42M Sell
53,953
-12,725
-19% -$714K 0.02% 602
2024
Q3 		$4.19M Sell
66,678
-9,858
-13% -$575K 0.04% 389
2024
Q2 		$4.52M Sell
76,536
-6,386
-8% -$399K 0.05% 338
2024
Q1 		$6.61M Buy
82,922
+4,132
+5% +$316K 0.07% 266
2023
Q4 		$6.36M Sell
78,790
-5,400
-6% -$384K 0.07% 259
2023
Q3 		$5.88M Sell
84,190
-9,999
-11% -$708K 0.07% 263
2023
Q2 		$6.51M Sell
94,189
-2,969
-3% -$211K 0.07% 269
2023
Q1 		$7.22M Buy
97,158
+9,892
+11% +$829K 0.09% 199
2022
Q4 		$8.13M Sell
87,266
-34,570
-28% -$3.34M 0.16% 129
2022
Q3 		$11.6M Buy
121,836
+834
+0.7% +$82.6K 0.24% 92
2022
Q2 		$11.2M Sell
121,002
-22,289
-16% -$2.18M 0.21% 103
2022
Q1 		$14.5M Buy
143,291
+13,903
+11% +$1.46M 0.22% 100
2021
Q4 		$13.3M Buy
129,388
+17,662
+16% +$1.63M 0.19% 113
2021
Q3 		$9.32M Hold
111,726
– – 0.15% 138
2021
Q2 		$9.32M Buy
111,726
+3,766
+3% +$308K 0.12% 176
2021
Q1 		$8.12M Sell
107,960
-59,526
-36% -$4.34M 0.12% 177
2020
Q4 		$11.4M Buy
167,486
+41,359
+33% +$2.69M 0.18% 124
2020
Q3 		$7.37M Buy
+126,127
New +$7.85M 0.13% 181
2020
Q1 		– Sell
-126
Closed -$9K – 394
2019
Q4 		$9K Hold
126
– – ﹤0.01% 577
2019
Q3 		$8K Sell
126
-1,526
-92% -$90.4K ﹤0.01% 590
2019
Q2 		$90K Buy
1,652
+1,557
+1,639% +$83.8K ﹤0.01% 504
2019
Q1 		$5K Buy
95
+80
+533% +$4.94K ﹤0.01% 703
2018
Q4 		$1K Buy
+15
New +$1.12K ﹤0.01% 635
2018
Q3 		– Sell
-25
Closed -$2K – 635
2018
Q2 		$2K Buy
+25
New +$1.65K ﹤0.01% 570
2017
Q4 		– Sell
-60
Closed -$5K – 523
2017
Q3 		$5K Sell
60
-13,655
-100% -$1.08M ﹤0.01% 476
2017
Q2 		$1.1M Buy
13,715
+974
+8% +$76.9K 0.04% 197
2017
Q1 		$1M Buy
12,741
+182
+1% +$14.5K 0.04% 196
2016
Q4 		$991K Buy
12,559
+305
+2% +$24.7K 0.04% 189
2016
Q3 		$1.09M Buy
12,254
+397
+3% +$37.5K 0.05% 175
2016
Q2 		$1.14M Buy
11,857
+22
+0.2% +$2.19K 0.05% 174
2016
Q1 		$1.23M Buy
11,835
+3,617
+44% +$352K 0.05% 169
2015
Q4 		$803K Buy
8,218
+70
+0.9% +$6.86K 0.03% 203
2015
Q3 		$786K Buy
8,148
+85
+1% +$8.94K 0.03% 199
2015
Q2 		$846K Buy
8,063
+711
+10% +$72.6K 0.03% 192
2015
Q1 		$759K Sell
7,352
-252
-3% -$25.5K 0.03% 193
2014
Q4 		$732K Buy
7,604
+246
+3% +$21.7K 0.03% 193
2014
Q3 		$586K Buy
7,358
+100
+1% +$7.88K 0.02% 197
2014
Q2 		$547K Sell
7,258
-470
-6% -$35.5K 0.02% 212
2014
Q1 		$579K Sell
7,728
-522
-6% -$36.9K 0.02% 200
2013
Q4 		$590K Buy
8,250
+1,305
+19% +$83.8K 0.02% 199
2013
Q3 		$394K Buy
6,945
+751
+12% +$44.8K 0.02% 217
2013
Q2 		$354K Buy
+6,194
New +$359K 0.01% 222

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Brinker Capital Investments's CVS Position: Q2 2026 in Review

Brinker Capital Investments increased its CVS Health (CVS) stake by 0.83% in Q2 2026, buying an estimated $33.4K and bringing the position to 45,562 shares worth $4.71M. The position accounts for 0.04% of the portfolio, ranked #401.

Brinker Capital Investments first reported a position in CVS in Q2 2013 and has held it in 48 quarters since. The position peaked at $14.5M in Q1 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Brinker Capital Investments held 45,562 shares of CVS Health worth $4.71M as of Q2 2026.
  • Brinker Capital Investments bought 374 CVS Health shares in Q2 2026, an estimated $33.4K.
  • CVS Health made up 0.04% of Brinker Capital Investments's portfolio in Q2 2026, its #401 holding.
  • Brinker Capital Investments first reported a position in CVS Health in Q2 2013 and has held it in 48 quarters since.
  • Brinker Capital Investments's CVS Health position peaked at $14.5M in Q1 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.